{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T14:06:15Z","timestamp":1793109975217,"version":"4.5.0"},"reference-count":21,"publisher":"American Society for Microbiology","issue":"3","license":[{"start":{"date-parts":[[2023,6,15]],"date-time":"2023-06-15T00:00:00Z","timestamp":1686787200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2023,6,15]],"date-time":"2023-06-15T00:00:00Z","timestamp":1686787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"DOI":"10.13039\/100004423","name":"World Health Organization","doi-asserted-by":"publisher","award":["2022\/1041859-0"],"award-info":[{"award-number":["2022\/1041859-0"]}],"id":[{"id":"10.13039\/100004423","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Microbiol Spectr"],"published-print":{"date-parts":[[2023,6,15]]},"abstract":"<jats:p>The markets have been flooded with hundreds of SARS-CoV-2 serology tests, and although there are many published reports on their performance, comparative reports are far fewer and tend to be limited to only a few tests. In this report, we comparatively assessed 35 rapid diagnostic tests or microtiter plate enzyme immunoassays (EIAs) using a large set of samples from individuals with a history of mild to moderate COVID-19, commensurate with the target population for serosurveillance, which included serum samples from individuals previously infected, at undetermined time periods, with other seasonal human coronaviruses, Middle East respiratory syndrome coronavirus (MERS-CoV), and SARS-CoV-1.<\/jats:p>","DOI":"10.1128\/spectrum.05101-22","type":"journal-article","created":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T15:46:04Z","timestamp":1683647164000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":4,"title":["Comprehensive, Comparative Evaluation of 35 Manual SARS-CoV-2 Serological Assays"],"prefix":"10.1128","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3425-9419","authenticated-orcid":true,"given":"Wayne","family":"Dimech","sequence":"first","affiliation":[{"name":"National Serology Reference Laboratory, Fitzroy, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon","family":"Curley","sequence":"additional","affiliation":[{"name":"National Serology Reference Laboratory, Fitzroy, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Subissi","sequence":"additional","affiliation":[{"name":"World Health Organization, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ute","family":"Str\u00f6her","sequence":"additional","affiliation":[{"name":"World Health Organization, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark D.","family":"Perkins","sequence":"additional","affiliation":[{"name":"World Health Organization, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Cunningham","sequence":"additional","affiliation":[{"name":"World Health Organization, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m2420"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013652"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00767-21"},{"key":"e_1_3_3_5_2","volume-title":"Advice on the use of point-of-care immunodiagnostic tests for COVID-19.","author":"World Health Organization","year":"2020","unstructured":"World Health Organization. 2020. Advice on the use of point-of-care immunodiagnostic tests for COVID-19. World Health Organization, Geneva, Switzerland."},{"key":"e_1_3_3_6_2","volume-title":"Expression of interest\u2014general information and timelines.","author":"World Health Organization","year":"2020","unstructured":"World Health Organization. 2020. Expression of interest\u2014general information and timelines. World Health Organization, Geneva, Switzerland. https:\/\/www.who.int\/docs\/default-source\/coronaviruse\/eoi_general-info_timelines.pdf?sfvrsn=215a8b28_5. Accessed 30 May 2022."},{"key":"e_1_3_3_7_2","volume-title":"FIND evaluation of SARS-COV-2 antibody (AB) detection tests.","author":"Foundation for New and Innovative Diagnostics","year":"2020","unstructured":"Foundation for New and Innovative Diagnostics. 2020. FIND evaluation of SARS-COV-2 antibody (AB) detection tests. Foundation for New and Innovative Diagnostics, Geneva, Switzerland. https:\/\/www.finddx.org\/covid-19\/find-evaluations-of-sars-cov-2-assays\/find-evaluations-of-sars-cov-2-ab-tests\/. Accessed 29 April 2023."},{"key":"e_1_3_3_8_2","first-page":"203","article-title":"Serological assays for SARS-CoV-2 infectious disease: benefits, limitations and perspectives","volume":"22","author":"Infantino M","year":"2020","unstructured":"Infantino M, Damiani A, Gobbi FL, Grossi V, Lari B, Macchia D, Casprini P, Veneziani F, Villalta D, Bizzaro N, Cappelletti P, Fabris M, Quartuccio L, Benucci M, Manfredi M. 2020. Serological assays for SARS-CoV-2 infectious disease: benefits, limitations and perspectives. Isr Med Assoc J 22:203\u2013210.","journal-title":"Isr Med Assoc J"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01167-21"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0244126"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)02346-1"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00763-2020"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa344"},{"key":"e_1_3_3_14_2","volume-title":"Target product profiles for priority diagnostics to support response to the COVID-19 pandemic v.1.0.","author":"World Health Organization","year":"2020","unstructured":"World Health Organization. 2020. Target product profiles for priority diagnostics to support response to the COVID-19 pandemic v.1.0. World Health Organization, Geneva, Switzerland."},{"key":"e_1_3_3_15_2","volume-title":"Coronavirus disease (COVID-19): serology, antibodies and immunity.","author":"World Health Organization Emergencies Preparedness","year":"2020","unstructured":"World Health Organization Emergencies Preparedness. 2020. Coronavirus disease (COVID-19): serology, antibodies and immunity. World Health Organization, Geneva, Switzerland. https:\/\/www.who.int\/news-room\/questions-and-answers\/item\/coronavirus-disease-covid-19-serology. Accessed 20 June 2020."},{"key":"e_1_3_3_16_2","volume-title":"Population-based age-stratified seroepidemiological investigation protocol for coronavirus 2019 (COVID-19) infection (version 2).","author":"World Health Organization Emergencies Preparedness","year":"2020","unstructured":"World Health Organization Emergencies Preparedness. 2020. Population-based age-stratified seroepidemiological investigation protocol for coronavirus 2019 (COVID-19) infection (version 2). World Health Organization, Geneva, Switzerland."},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00769-003-0734-5"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2022.105121"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jim.2020.112909"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2020.11.164"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2022.115659"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)00163-5"}],"container-title":["Microbiology Spectrum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/spectrum.05101-22","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/spectrum.05101-22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,15]],"date-time":"2023-06-15T13:25:28Z","timestamp":1686835528000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/spectrum.05101-22"}},"subtitle":[],"editor":[{"given":"Oliver","family":"Laeyendecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2023,6,15]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,6,15]]}},"alternative-id":["10.1128\/spectrum.05101-22"],"URL":"https:\/\/doi.org\/10.1128\/spectrum.05101-22","relation":{},"ISSN":["2165-0497"],"issn-type":[{"value":"2165-0497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,15]]},"assertion":[{"value":"2022-12-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-04-14","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-05-09","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e05101-22"}}